Published by Coherent Market Insights
Posted on September 28, 2021
5 min readLast updated: February 1, 2026
The Human Microbiome Market is poised for growth by 2028, driven by R&D and innovation, with North America leading due to high IBD prevalence.
Human Microbiome Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Human Microbiome Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/182
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.
Market Overview:
The human microbiota (the various microbial communities constantly living in the body) is now one of the largest researched areas in clinical biology. There are many interesting areas of study in this field, all of which have great importance to helping us understand and ultimately control some of the common diseases that plague our society today such as diabetes, obesity, heart disease, and more. The human intestinal tract is home to several hundred thousand microbial species. Together these bacteria form a community that is tightly connected to the immune system of the body and very closely associates with the DNA of each patient. The study of the human microbiota aid in the prevention of Crohn’s disease and ulcerative colitis condition.
Market Drivers:
Growing research & development activities by key players in order to get a better understanding of microbes on human health is augmenting growth of the Human Microbiome Market. For instance, in November 2019, Nestlé has entered into a partnership with the University of California San Diego Center for Microbiome Innovation (CMI) to increase the understanding of the microbiome’s impact on human health and to accelerate the development of innovative nutritional solutions.
The increasing focus of key manufacturers to launch new and innovative medical food products is uplifting growth of the market. For instance, in June 2019, Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has launched the first end-to-end sample prep kit on the market at the upcoming ASM Microbe 2019 event.
COVID-19 Analysis:
The market of human microbiome market was negatively impacted during the spread of COVID-19 infections. It has severely affected the entire supply chain of the medical food industry due to social distancing norms and lockdown. However, later on, the market has seen positive growth as COVID-19 directly affects the immune system and the use of probiotics improves immunity. This has defiantly raised the demand for probiotics during COVID-19 times.
Key Takeaway:
North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of inflammatory bowel disease in the region. According to the Centers for Disease Control and Prevention’s, Inflammatory Bowel Disease (IBD) in the United States. About 1 percent of the U.S., or 3 million people, live with inflammatory bowel disease (IBD). People are most often diagnosed with Crohn’s disease or ulcerative colitis between ages 15 and 30
The human microbiome market is expected to exhibit a CAGR of XX % over the forecast period, owing to the growing adoption of growth strategies such as mergers &acquasition among key players. For instance, in December 2020, Novozymes has acquired Microbiome Labs. Based in Illinois, US. Microbiome Labs offers a comprehensive portfolio of proprietary probiotic and microbiome solutions and is a vital player in the consumer health industry.
Buy This Premium Report Of Human Microbiome Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/182
In this study, the years considered to estimate the market size of Human Microbiome are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Human Microbiome Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Human Microbiome Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Human Microbiome Market: Determined By Market Concentration Rate, New Entrants, Products, Services And Solutions 2028 appeared first on Gatorledger.
The article discusses the growth and trends in the Human Microbiome Market from 2021 to 2028.
COVID-19 initially disrupted the market but later increased demand for probiotics due to their immune-boosting properties.
North America is significant due to the high prevalence of inflammatory bowel disease, driving market demand.
Explore more articles in the Research Reports category
